Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1975 Oct;37(10):1059–1063. doi: 10.1136/hrt.37.10.1059

Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure.

S Talbot, A J Smith
PMCID: PMC482919  PMID: 127594

Abstract

Symptoms due to orthostatic and exertional hypotension occurred in 23-4 per cent of 448 hypertensive patients treated with guanethidine, debrisoquine, or bethanidine. Symptoms were significantly more frequent in patients treated with guanethidine than in those treated with bethanidine or debrisoquine. Women rather than men and patients with radiological evidence of cardiomegaly, electrocardiographic evidence of left ventricular hypertrophy, or ST/T wave changes, developed these symptoms significantly more often than other patients. A raised blood urea was found more frequently in patients with postural hypotensive symptoms. Characteristically guanethidine produced early morning postural hypotensive symptoms, wheras hypotensive symptoms caused by bethanidine and debrisoquine occurred at other times of the day and particularly one to two hours after tablet ingestion. Debrisoquine and guanethidine had a significantly greater negative chronotropic effect than bethanidine. It is suggested that negative chronotropic effects of these drugs may potentiate hypotensive symptoms in patients with cardiovascular, renal, or cerebrovascular disease. It should be possible to minimize symptoms of postural hypotension by attention to predisposing factors and selection of treatment accordingly.

Full text

PDF
1059

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bath J., Pickering D., Turner R. Clinical experience with bethanidine in treatment of hypertension. Br Med J. 1967 Dec 2;4(5578):519–521. doi: 10.1136/bmj.4.5578.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CRANSTON W. I., BROWN W. DIURNAL VARIATION IN PLASMA VOLUME IN NORMAL AND HYPERTENSIVE SUBJECTS. Clin Sci. 1963 Aug;25:107–114. [PubMed] [Google Scholar]
  3. GAFFNEY T. E., BRAUNWALD E., COOPER T. Analysis of the acute circulatory effects of guanethidine and bretylium. Circ Res. 1962 Jan;10:83–88. doi: 10.1161/01.res.10.1.83. [DOI] [PubMed] [Google Scholar]
  4. INNES I. R., KRAYER O., WAUD D. R. The action of Rauwolfia alkaloids on the heart rate and on the functional refractory period of atrio-ventricular transmission in the heartlung preparation of the dog. J Pharmacol Exp Ther. 1958 Dec;124(4):324–332. [PubMed] [Google Scholar]
  5. Kahler R. L., Gaffney T. E., Braunwald E. THE EFFECTS OF AUTONOMIC NERVOUS SYSTEM INHIBITION ON THE CIRCULATORY RESPONSE TO MUSCULAR EXERCISE. J Clin Invest. 1962 Nov;41(11):1981–1987. doi: 10.1172/JCI104656. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES